Page 155 - Glucose Monitoring Devices

156 CHAPTER 7 Clinical impact of CGM use

[40] (UK), N. C. G. C. In: Type 1 diabetes in adults: diagnosis and management. UK:
National Institute for Health and Care Excellence; 2015.
[41] Danne T, et al. International consensus on use of continuous glucose monitoring.
Diabetes Care 2017;40:1631e40.
[42] Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. Continuous glucose monitoring
used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Dia-
betes Research and Clinical Practice 1999;46:183e90.
[43] Schaepelynck-Belicar P, Vague P, Simonin G, Lassmann-Vague V. Improved meta-
bolic control in diabetic adolescents using the continuous glucose monitoring system
(CGMS). Diabetes and Metabolism 2003;29:608e12.
[44] Kaufman FR, et al. A pilot study of the continuous glucose monitoring system: clinical
decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Dia-
betes Care 2001;24:2030e4.
[45] Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved meta-
bolic control in pediatric patients with type 1 diabetes: a controlled crossover study.
Pediatrics 2003;111:933e8.
[46] Tanenberg R, et al. Use of the continuous glucose monitoring system to guide therapy
in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clinic
Proceedings 2004;79:1521e6.
[47] Chico A, Vidal-Rios P, Subira M, Novials A. The continuous glucose monitoring sys-
tem is useful for detecting unrecognized hypoglycemias in patients with type 1 and
type 2 diabetes but is not better than frequent capillary glucose measurements for
improving metabolic control. Diabetes Care 2003;26:1153e7.
[48] Garg SK, Schwartz S, Edelman SV. Improved glucose excursions using an implantable
real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care
2004;27:734e8.
[49] Garg S, Jovanovic L. Relationship of fasting and hourly blood glucose levels to HbA1c
values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day
continuous glucose sensor. Diabetes Care 2006;29:2644e9.
[50] Bailey TS, Zisser HC, Garg SK. Reduction in hemoglobin A1C with real-time contin-
uous glucose monitoring: results from a 12-week observational study. Diabetes Tech-
nology and Therapeutics 2007;9:203e10.
[51] Deiss D, et al. Improved glycemic control in poorly controlled patients with type 1 dia-
betes using real-time continuous glucose monitoring. Diabetes Care 2006;29:2730e2.
[52] Beck RW, et al. Effect of continuous glucose monitoring on glycemic control in adults
with type 1 diabetes using insulin injections. Journal of the American Medical
Association 2017;317:371.
[53] Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group,
et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. The
New England Journal of Medicine 2008;359:1464e76.
[54] Lind M, et al. Continuous glucose monitoring vs conventional therapy for glycemic
control in adults with type 1 diabetes treated with multiple daily insulin injections:
the GOLD randomized clinical trial. Journal of the American Medical Association
2017;317:379e87.
[55] El-Laboudi AH, Godsland IF, Johnston DG, Oliver NS. Measures of glycemic vari-
ability in type 1 diabetes and the effect of real-time continuous glucose monitoring.
Diabetes Technology and Therapeutics 2016;18:806e12.